(Q34108107)

31 July 2017

1 reference

title

Therapy for childhood acute myeloid leukemia: role of allogeneic bone marrow transplantation (English)

1 reference

31 July 2017

main subject

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

Abella E

1

1 reference

31 July 2017

Ravindranath Y

series ordinal

2

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

529-538

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-000-0107-8

31 July 2017

exact match

0 references

cites work

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-000-0107-8

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome

21 January 2018

1 reference

12 December 2020

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

12 December 2020

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia

1 reference

12 December 2020

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse

1 reference

12 December 2020

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplanta

1 reference

12 December 2020

U.S. childhood cancer survival, 1973-1987.

1 reference

12 December 2020

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

12 December 2020

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498

1 reference

12 December 2020

Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group

1 reference

12 December 2020

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

1 reference

12 December 2020

Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group

1 reference

12 December 2020

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

12 December 2020

Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation

1 reference

12 December 2020

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

12 December 2020

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

1 reference

12 December 2020

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osse

1 reference

12 December 2020

Revised classification of acute myeloid leukemia

1 reference

12 December 2020

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia

1 reference

12 December 2020

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87

1 reference

12 December 2020

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases

1 reference

12 December 2020

Leukemia: management of relapse after allogeneic bone marrow transplantation

1 reference

12 December 2020

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

12 December 2020

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

12 December 2020

Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party.

1 reference

12 December 2020

Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission

1 reference

12 December 2020

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia

1 reference

12 December 2020

Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Treatment of acute myelogenous leukemia in children and adults

1 reference

12 December 2020

Autologous versus allogeneic BMT in AML: the European experience. Report of the EBMT--Pediatric Diseases Working Party

1 reference

12 December 2020

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the Internation

1 reference

12 December 2020

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

12 December 2020

A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for B

1 reference

12 December 2020

Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.

1 reference

12 December 2020

Acute myeloid leukemia

1 reference

12 December 2020

Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation

1 reference

12 December 2020

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

12 December 2020

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

1 reference

12 December 2020

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

12 December 2020

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party

1 reference

12 December 2020

Allogeneic and autologous bone marrow transplantation in AML in first remission. The Spanish experience

1 reference

12 December 2020

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia

1 reference

12 December 2020

Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)

1 reference

12 December 2020

Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome

1 reference

12 December 2020

The present role of bone marrow and stem cell transplantation in the therapy of children with acute leukemia

1 reference

12 December 2020

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821

1 reference

12 December 2020

Definition of a standard-risk group in children with AML

1 reference

12 December 2020

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

12 December 2020

Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis

1 reference

12 December 2020

Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation

1 reference

12 December 2020

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

12 December 2020

10.1007/S11912-000-0107-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1015340702

0 references

1 reference